Delivery Order SPE2DB22D3501-SPE2DB25FUN80

Award Date 2/13/25
Potential Completion Date 3/7/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $21,156.78 and a completion date of April 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LORBRENA 100 MG TABLET 30S. The $21,930.68 contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a range of medical commodities to support military treatment programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,578.39, is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract, valued at $10,578.39, is for the delivery of 4564002715 - LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product LORBRENA 100 MG TABLET 30S. The contract has a ceiling value of $42,313.56 and a performance period through April 16, 2024. This delivery order is part of a broader indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FTK17, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $10,578.39. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 27, 2023. This award is not associated with a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,156.78 Firm Fixed Price delivery order is for the supply of LORBRENA 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of December 12, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,965.33 Firm Fixed Price Delivery Order is for the supply of 4,564,361,949 units of the pharmaceutical product LORBRENA 100 MG TABLET 30S, with a completion date of May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LORBRENA 100 MG TABLET 30S. The contract has an award value of $21,156.78 and a completion date of February 20, 2024. It is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide LORBRENA 100 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,344.30, a firm fixed price, and a completion date of February 20, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUN80
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/22/25, 8:10 PM